Your browser doesn't support javascript.
loading
Signal Enhancement in the HPLC-ESI-MS/MS analysis of spironolactone and its metabolites using HFIP and NH4F as eluent additives.
Takkis, Kalev; Aro, Rudolf; Kõrgvee, Lenne-Triin; Varendi, Heili; Lass, Jana; Herodes, Koit; Kipper, Karin.
Afiliación
  • Takkis K; Institute of Chemistry, University of Tartu, 14a Ravila Street, Tartu, 50411, Estonia.
  • Aro R; Institute of Chemistry, University of Tartu, 14a Ravila Street, Tartu, 50411, Estonia.
  • Kõrgvee LT; Children's Clinic, Tartu University Hospital, N. Lunini 6, Tartu, 51014, Estonia.
  • Varendi H; Institute of Biomedicine and Translational Medicine, Department of Pharmacology, University of Tartu, Ravila 19, Tartu, 50411, Estonia.
  • Lass J; Children's Clinic, Tartu University Hospital, N. Lunini 6, Tartu, 51014, Estonia.
  • Herodes K; Pharmacy Department, Tartu University Hospital, L. Puusepa 8, Tartu, 51014, Estonia.
  • Kipper K; Institute of Biomedicine and Translational Medicine, Department of Microbiology, University of Tartu, Ravila 19, Tartu, 50411, Estonia.
Anal Bioanal Chem ; 409(12): 3145-3151, 2017 May.
Article en En | MEDLINE | ID: mdl-28224249
ABSTRACT
This paper describes an LC-MS/MS method to determine the concentration of spironolactone and its metabolites 7-alpha-methylthiospironolactone and canrenone in blood plasma samples. The resulting assay is simple (using protein precipitation for sample preparation) and sensitive (the lower limit of quantification is close to 0.5 ng/ml) while requiring only 50 µl of plasma, making it especially suitable for analyzing samples obtained from pediatric and neonatal patients where sample sizes are limited. The sensitivity is achieved by using ammonium fluoride as an eluent additive, which in our case amplifies the signal from our analytes in the plasma solution on average about 70 times. The method is fully validated according to the European Medicines Agency's guideline and used for the measurement of pediatric patients' samples in clinical trials for evaluating oral spironolactone's and its metabolites' pharmacokinetics in children up to 2 years of age.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Espironolactona / Canrenona / Cromatografía Líquida de Alta Presión / Antagonistas de Receptores de Mineralocorticoides / Espectrometría de Masas en Tándem Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Anal Bioanal Chem Año: 2017 Tipo del documento: Article País de afiliación: Estonia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Espironolactona / Canrenona / Cromatografía Líquida de Alta Presión / Antagonistas de Receptores de Mineralocorticoides / Espectrometría de Masas en Tándem Tipo de estudio: Guideline Límite: Humans Idioma: En Revista: Anal Bioanal Chem Año: 2017 Tipo del documento: Article País de afiliación: Estonia
...